Postdoctoral training opportunity in translational drug discovery for Alzheimer’s disease. The Rizzo laboratory at The University of Pittsburgh School of Medicine - Aging Institute is seeking an exceptional, ambitious, and highly motivated postdoctoral associate to join our MODEL-AD and TREAT-AD consortiums. The lab utilizes multiple methods including genetics, protein biochemistry, behavioral pharmacology, and translational pharmacokinetics and pharmacodynamics. This is an excellent opportunity for motivated individuals interested in drug discovery and preclinical translational approaches for Alzheimer’s disease research to make seminal contributions to the field. The incumbent will be expected to lead an independent project supporting preclinical translational studies combining EEG, behavior, and biomarkers in mouse models of late-onset Alzheimer’s Disease to investigate in vivo target engagement and the potential efficacy of novel therapeutic interventions.

Qualifications: A Ph.D. (awarded in the last 5 years) or MD (awarded in the last 10 years) in biological science (or related field) is required.

The University of Pittsburgh is committed to championing all aspects of diversity, equity, inclusion, and accessibility within our community. This commitment is a fundamental value of the University and is crucial in helping us advance our mission, which includes attracting and retaining diverse workforces. We will continue to create and maintain an environment that allows individuals to discover, belong, contribute, and grow, while honoring the experiences, perspectives, and unique identities of all.

The University of Pittsburgh is an Affirmative Action/Equal Opportunity Employer and values equality of opportunity, human dignity and diversity. EOE, including disability/vets.

The University of Pittsburgh requires all Pitt constituents (employees and students) on all campuses to be vaccinated against COVID-19 or have an approved exemption. Visit hr.pitt.edu/contact-ohr to learn more.